ABSTRACT
Introduction Sub-Saharan Africa is projected to have the highest increase in the number of people with diabetes worldwide. However, the drivers of diabetes in this region have not been clearly elucidated. The aim of this study was to evaluate the incidence of diabetes and the predictors of progression in a population-based cohort with impaired fasting glucose (IFG) in Malawi.
Methods We used data from an extensive rural and urban non-communicable disease survey. One hundred seventy-five, of 389 individuals with impaired fasting glucose (IFG) at baseline, age 48 ±15 years and body mass index 27.5 ±5.9 kg/m2 were followed up for a median of 4.2 years (714 person-years). Incidence rates were calculated, and predictors of progression to diabetes were analysed using multivariable logistic regression models, with overall performance determined using receiver operator characteristics (ROC) curves.
Results The median follow-up was 4.2 (IQR 3.4 – 4.7) years. Forty-five out of 175 (26%) progressed to diabetes. Incidence rates of diabetes were 62.9 per 1000 person-years 95% CI, 47.0-84.3. The predictors of progression were higher; age (odds ratio [OR] 1.48, 95% CI 1.01-2.19, P=0.046), BMI (OR 1.98, 95% CI 1.34-2.94, P=0.001), waist circumference (OR 2.50, 95% CI 1.60-3.91,P<0.001), waist-hip ratio (OR 1.40, 95%CI 0.98-2.01, P=0.03), systolic blood pressure (OR 1.56, 95% CI 1.10-2.21, P=0.01), fasting plasma glucose (OR 1.53, 95%CI 1.08-2.16, P=0.01), cholesterol (OR 1.44, 95% CI 1.00-2.08, P=0.05) and low-density lipoprotein cholesterol (OR 1.80, 95% 1.23-2.64, P=0.002). A simple model combining fasting plasma glucose and waist circumference was predictive of progression to diabetes (ROC area under the curve=0.79)
Conclusion The incidence of diabetes in people with IFG in Malawi is higher than those seen in Europe (35.0 per 1,000 person-years) but similar to those seen in India (61.0 per 1,000 person-years). Predictors of progression are like those seen in other populations. A simple chart with probabilities of progression to diabetes based on waist circumference and fasting plasma glucose could be used to identify those at risk of progression in clinical settings in sub-Saharan Africa.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement through a strategic award to MJN (Project Reference: MC_UP_1204/16). The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All activities were approved by the local ethics committee (protocol no. 17/12/1953, National Health Sciences Research Committee, Lilongwe. Malawi) and complied with the Declaration of Helsinki. Written, informed consent was obtained from all the participants before recruitment into the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The study found that the incidence rates of diabetes in people with impaired fasting glucose in Malawi are higher than that seen in Europe or the USA but similar to that seen in India.
Waist circumference and the initial blood glucose concentration are the strongest predictors of progression. A simple map with probabilities of progression to diabetes based on waist circumference and fasting plasma glucose could be used to identify those at risk of progression in Sub-Saharan Africa.
Data Availability
The cross-sectional NCD data underlying this analysis are available for download via the LSHTM Data Compass Repository (https://doi.org/10.17037/DATA.00000961). However, owing to data protection concerns, there are restrictions on access to this underlying data. Given their linkages to the longitudinal data produced by MEIRU, these data require anonymization using statistical disclosure control techniques to make them sufficiently safe for direct access. The anonymization process is scheduled for the last quarter of 2022. In the meantime, data access to bona fide researchers for specific research purposes is possible through completing a data request form on the LSHTM data compass repository. Once the anonymization process has been completed, direct access will be granted via the same repository.
